NCT06674772 Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
| NCT ID | NCT06674772 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute |
| Condition | Headache (Migraine) |
| Study Type | OBSERVATIONAL |
| Enrollment | 440 participants |
| Start Date | 2022-11-29 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 440 participants in total. It began in 2022-11-29 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
Eligibility Criteria
Inclusion Criteria: * Migraine patients according to ICHD-3 criteria * Healthy controls paired to patient age and sex, without headache and without first degree family history of headache. Exclusion Criteria: * Presence of any major medical or neurological illness. * Presence of any salivary gland malfunction. * Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment. * Active migraine preventive treatment. * Pregnant or breastfeeding female.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06674772 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 75 Years, studying Headache (Migraine). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06674772 currently recruiting?
Yes, NCT06674772 is actively recruiting participants. Contact the research team at ppozo@vhebron.net for enrollment information.
Where is the NCT06674772 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT06674772 clinical trial?
NCT06674772 is sponsored by Hospital Universitari Vall d'Hebron Research Institute. The trial plans to enroll 440 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.